A new type of bone marrow transplant can cure sickle cell disease with only half of the donor's cell proteins matching, ...

Traditional therapies, such as cognitive-behavioral therapy (CBT), psychodynamic therapy, and supportive counseling, have ...

Intra-Cellular Therapies (NASDAQ:ITCI – Get Free Report) was downgraded by research analysts at Mizuho from an “outperform” ...

High dose and low dose of TSHA-102 continue to be generally well tolerated with no treatment-related SAEs or DLTs in all ...

Unpacking your problems for an hour each week with a professional is being talked about for all the wrong reasons ...

Dermatologists are practicing in an “era of good efficacy” of nonsteroidal topical therapies for psoriasis, and they can help patients access newer topical medications by working with pharmacies that ...

Dr Pandey shares key insights on dosing, monitoring, and patient education to sustain therapy and improve outcomes. Essential ...

Intra-Cellular Therapies, Inc., a biopharmaceutical company, focuses on the discovery, clinical development, and commercialization of small molecule drugs that address medical needs primarily in ...

The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.

Learn more about whether AstraZeneca PLC or Intra-Cellular Therapies, Inc. is a better investment based on AAII's A+ Investor ...